Effect of COVID-19 lockdown and Ramadan fasting on glucose control in patients with diabetes: a glucose monitoring study

Author(s):  
Radwa Helal ◽  
Nader Lessan ◽  
Dr. Tanveer Ashraf ◽  
Maria Majeed
2017 ◽  
Vol 10 ◽  
pp. 117863291773507 ◽  
Author(s):  
Vivien Leung ◽  
Kristal Ragbir-Toolsie

Hyperglycemia has long been recognized to have detrimental effects on postoperative outcomes in patients undergoing surgery. The manifestations of uncontrolled diabetes are manifold and can include risk of hyperglycemic crises, postoperative infection, poor wound healing, and increased mortality. There is substantial literature supporting the role of diligent glucose control in the prevention of adverse surgical outcomes, but considerable debate remains as to the optimal glucose targets. Hence, most organizations advocate the avoidance of hypoglycemia while striving for adequate glucose control in the perioperative period. These objectives can be accomplished with careful preoperative evaluation, clear patient instructions the day of surgery, frequent blood glucose monitoring during the perioperative period, and use of effective strategies for insulin initiation and titration. This article highlights the major issues concerning patients with diabetes undergoing surgery and reviews the management recommendations put forth by general consensus guidelines and expert opinion.


2013 ◽  
Vol 09 (01) ◽  
pp. 21 ◽  
Author(s):  
Giulio Frontino ◽  
Franco Meschi ◽  
Riccardo Bonfanti ◽  
Andrea Rigamonti ◽  
Roseila Battaglino ◽  
...  

The prevalence of diabetes is increasing. Improved glucose control is fundamental to reduce both long-term micro- and macrovascular complications and short-term complications, such as diabetic ketoacidosis and severe hypoglycemia. Frequent blood glucose monitoring is an essential part of diabetes management. However, almost all available blood glucose monitoring devices are invasive. This determines a reduced patient compliance, which in turn reflects negatively on glucose control. Therefore, there is a need to develop noninvasive glucose monitoring devices that will reduce the need of invasive procedures, thus increasing patient compliance and consequently improving quality of life and health of patients with diabetes.


2021 ◽  
Vol 22 (4) ◽  
pp. 221-224
Author(s):  
Hae Dong Choi ◽  
Jun Sung Moon

Diabetes is one of the major comorbidities associated with increased risk of mortality and severe clinical outcomes in coronavirus disease 19 (COVID-19) patients. Thus, timely and appropriate vaccination is the most effective strategy for mitigating the risk of COVID-19 infection in people with diabetes. Recent studies have shown that immune response after vaccination is significant in both diabetes and non-diabetes groups, but slightly lower in patients with diabetes. Inadequate glucose control might impair the immune response. Blood glucose monitoring is required more often than usual for several days after vaccination. If a patient’s blood glucose is not controlled adequately, appropriate management should be provided.


Sign in / Sign up

Export Citation Format

Share Document